difference between glp 1 and glp 2 versus Emerging Role of Dual GLP-1 GIP Receptor Agonists Current Insights, Advantages and Challenges

Mounjaro generated $9.0 billion in H1 2025 alone, up 90% year-over-year

Cottage cheese An underrated high-protein option with a mild flavor and soft texture

CVS Restores Coverage of Lillys Zepbound, Adds Oral Obesity Drug Foundayo Nicholas Jacobus Key Takeaways Zepbounds return as a preferred option reverses a prior formulary exclusion that maintained Wegovy coverage, underscoring how net pricing and rebate contracting drive PBM obesity access decisions

Liu J, Wang F, Liu S, Du J, Hu X, Xiong J, et al

Compounded semaglutide offers a reliable alternative when these name-brand medications are not available

Some research suggests that eating regular, structured meals rather than constant grazing may support GLP-1 response